en
lv
ru
Investors
Corporate Governance
Financial Calendar
Financial News
Presentations
Documents
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Sponsorship and support
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Board
Structure
Supervisory Council
Senior Executive Team
Auditing Committee
Olainfarm Worldwide
Responsibility
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Procurements
Awards
History
Articles of Association
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Pharmacovigilance
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Investors
Investors
07.25.2015
Investors
Documents
Information on Shares
Dividends
Analysts
Corporate Governance
Financial Calendar
Financial News
Investor Contacts
Presentations
Shareholders’ Meetings
Search
Recent Posts
In 2019, Olainfarm Group successfully started its transformation, which has already yielded significant results
May 6, 2020
In March Olainfarm group sales increased by 22%; manufacturing and distribution processes are operating normally
April 20, 2020
JSC Olainfarm decide to gift Pauls Stradiņš Clinical University Hospital artificial lung ventilation devices in the worth of EUR 100 thousand
March 26, 2020
JSC OlainFarm appoints a new member of the Management Board of Latvijas aptieka
March 19, 2020
February sales in several markets exceeded prior year results; procedures are in place to limit the spread of coronavirus
March 18, 2020
